| These Explosive Potential Catalysts Could Generate Breakout Buzz For (NYSE American: MAIA)
#1. MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas
From Monday morning's article:
"THIO is a versatile anti-cancer agent that has demonstrated positive results in multiple difficult to treat cancer types, including pediatric high-grade glioma, which is among the most treatment-resistant cancers in children. THIO is shown to activate the immune system while evading tumor immunosuppression, a novel therapeutic approach for this devastating childhood disease," said MAIA Chairman and Chief Executive Officer Vlad Vitoc, M.D. "We are proud to receive the FDA’s Rare Pediatric Disease designation for THIO, which significantly bolsters our plans for continuing research in the PDHGG indication."
#2. A major analyst targets suggest serious upside potential (triple-digit!).
Noble Capital Markets - $14.00 Target - (Potential upside of 500+% from Monday's close)
Key Report Details:
Conclusion. Based on the results to date, we look forward to the interim data update and preliminary top-line results from the THIO-001 trial. We are reiterating our Outperform rating and $14 price target.
#3. MAIA has a relatively low float (volatility potential may be explosive).
Sporting a float of roughly 19.54Mn shares, according to Yahoo Finance, volatility potential could pop up in a flash.
Volatility could be part of the reason why MAIA was able to jump a $1.00+ from a mid-November low to an early December high.
#4. MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer
From the article:
"THIO is showing a survival benefit for patients with advanced NSCLC. As our follow-up continues, we have noted that three of the earliest patients enrolled are approaching 17-month survival. We’re on track to achieve our survival goals in third-line therapy," said Vlad Vitoc, M.D., Chairman and Chief Executive Officer of MAIA. "THIO’s outperformance to date supports our thesis that our telomere targeting agent could become a treatment option for people suffering from advanced NSCLC." -----
Coverage is officially initiated on MAIA Biotechnology, Inc. (NYSE American: MAIA).
I'll be in touch with updates when necessary. Talk again soon.
All the best, Dane James Editor Market Pulse Today
(Remember: St-ock Prices Could Be Significantly Lower Now From The Original Dates I Provided.)
MarketPulseToday.com (“MarketPulseToday” or “MPT” ) is owned by Thousand Sun Mediaa LLC, a limited liability company. Data is provided from third-party sources and MarketPulseToday ("MPT") is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile I bring to your attention. We do not provide personalized fin-ancial advice, are not finan-cial advisors, and our opinions are not suitable for all in-vest-ors.
Pursuant to an agreement between Thousand Sun Media LLC and TD Media LLC, Thousand Sun Media LLC has been hired by TD Media LLC for a period beginning on 12/16/2024 and ending on 12/17/2024 to publicly disseminate information about (MAIA:US) via digital communications. Under this agreement, Thousand Sun Media LLC has been paid five thousand USD (“Funds”) to disseminate information about (MAIA:US) via digital communications.
Neither Thousand Sun Media LLC, TD Media LLC and their member own shares of (MAIA:US).
Please see important disclosure information here: https://marketpulsetoday.com/disclosure/maia/
The single member of Thousand Sun Media LLC is also the single member of TD Media LLC.
Pursuant to an agreement between TD Media LLC and Sica Media LLC, TD Media LLC has been hired for a period beginning on 12/16/2024 and ending on 12/17/2024 to publicly disseminate information about (MAIA:US) via digital communications. Under this agreement, we have been paid fifty-eight thousand USD (“Funds”). These Funds were part of the funds that TD Media LLC received from a third party who did not receive the funds from the issuer and does not own st-ock in the issuer but the reader should assume that the clients of the third party own shares in the issuer that they will liquidate at or near the time you receive this communication, which has the potential to hurt share prices. To date TD Media LLC has been compensated a total of two hundred and fifty-nine thousand five hundred USD to disseminate information about (MAIA:US) via digital communications.
Please see important disclosure information here: https://lifewatermedia.com/disclosure/maia/ | 
No comments:
Post a Comment